SCHEMBL7549667

SCHEMBL7549667

O=C(Nc1ccccc1Cl)Nc1cccc(C(F)(F)F)c1O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 1/20 0.59
MEN1 O00255 6/20 0.54
KMT2A Q03164 6/20 0.54
KDM4E B2RXH2 4/20 0.54
TRPV1 Q8NER1 3/20 0.50
GRIK1 P39086 1/20 0.50
MAPT P10636 4/20 0.49
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49
LMNA P02545 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
POLB P06746 2/20 0.49
CASP3 P42574 2/20 0.49
SENP8 Q96LD8 2/20 0.49
SENP7 Q9BQF6 2/20 0.49
GAA P10253 2/20 0.49
MAPK1 P28482 2/20 0.49
NPSR1 Q6W5P4 2/20 0.49
SENP6 Q9GZR1 1/20 0.49
TDP1 Q9NUW8 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7549619 0.90 MEN1 (0.56) KDRMEN1KMT2AKDM4ETRPV1
SCHEMBL6823287 0.88 CXCR2 (0.60) KDRMEN1KMT2AKDM4ETRPV1
SCHEMBL5612816 0.82 MEN1 (0.58) KDRMEN1KMT2AKDM4ETRPV1
SCHEMBL3710835 0.82 HTT (0.56) MEN1KMT2AKDM4ETRPV1MAPT
SCHEMBL7490879 0.80 ALDH1A1 (0.52) KDRMEN1KMT2AKDM4ETRPV1
SCHEMBL7487115 0.79 LMNA (0.55) MEN1KMT2AKDM4EMAPTNPC1
SCHEMBL10458447 0.79 KDM4E (0.72) MEN1KMT2AKDM4EGRIK1MAPT
SCHEMBL5595319 0.77 RAB9A (0.60) MEN1KMT2AKDM4ETRPV1MAPT
SCHEMBL4351128 0.77 EPHX2 (0.61) KDRMEN1KMT2ATRPV1GRIK1
SCHEMBL5526395 0.77 GRIK1 (0.51) KDRMEN1KMT2AKDM4ETRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020128321-A1 IL-8 receptor antagonists SMITHKLINE BEECHAM CORPORATION 2002-09-12 US disclosed
US-6262113-B1 HYDROXY- OR MERCAPTO-PHENYLUREAS SMITHKLINE BEECHAM CORPORATION 2001-07-17 US disclosed
US-6211373-B1 Phenyl urea antagonists of the IL-8 receptor SMITHKLINE BEECHAM CORPORATION 2001-04-03 US disclosed
US-5780483-A IL-8 receptor antagonists SMITHKLINE BEECHAM CORPORATION (US) 1998-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128321-A1 IL-8 receptor antagonists CXCL8, CCR8, IL1RN KDR 793/4885MEN1 4754/4885KMT2A 3978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.